IFNG and neoplasm: Quantitation of tumor tracer uptake illustrated a significant increase in IFNγ tracer accumulation in tumors from ICI-treated (25.23 ± 6.48 %ID/mL) versus untreated mice (16.22 ± 2.68 %ID/mL, p<0.00055, Figures 1C, D).